You just read:

Goodwin Biotechnology and MD Anderson Cancer Center Collaborate on the GMP Manufacturing of a Fusion Protein Conjugate that Potentially Represents a Critical Advance in Oncology

News provided by

Goodwin Biotechnology, Inc.

Jun 04, 2012, 08:53 ET